ARTICLE | Company News
Biomerica, OraVax deal
April 20, 1998 7:00 AM UTC
BMRA acquired an exclusive license to ORVX's Cytotoxin Associated Gene A ( CagA) for diagnostic use. BMRA will develop physician office and clinical laboratory tests based on CagA to detect H. pylori....